| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 01/19/1999 | CA2061607C 1-biphenylimidazole derivatives, their preparation and their therapeutic use |
| 01/18/1999 | CA2237160A1 Gida1 |
| 01/18/1999 | CA2237147A1 Novel ratb |
| 01/15/1999 | CA2220849A1 A human pelota homolog |
| 01/14/1999 | WO1999001764A2 METHOD FOR DETERMINING GnRH RECEPTORS |
| 01/14/1999 | WO1999001556A2 IMPROVED ANTI-IgE ANTIBODIES AND METHOD OF IMPROVING POLYPEPTIDES |
| 01/14/1999 | WO1999001553A1 Murine and human cerberus-like proteins and compositions comprising them |
| 01/14/1999 | WO1999001541A1 IKK-α PROTEINS, NUCLEIC ACIDS AND METHODS |
| 01/14/1999 | WO1999001472A1 Cyclic azapeptides with angiogenic effect |
| 01/14/1999 | WO1999001466A1 Secreted proteins and polynucleotides encoding them |
| 01/14/1999 | WO1999001458A1 Crystalline macrolides and process for their preparation |
| 01/14/1999 | WO1999001455A1 Compounds |
| 01/14/1999 | WO1999001454A1 Imidazopyrimidines and imidazopyridines for the treatment of neurological disorders |
| 01/14/1999 | WO1999001452A1 Novel cycloalkyl substituted imidazoles |
| 01/14/1999 | WO1999001451A1 Azetidinylpropylpiperidine derivatives, intermediates and use as tachykinin antagonists |
| 01/14/1999 | WO1999001450A1 POLYMORPHS OF 8-CHLORO-6, 11-DIHYDRO-11- (4-PIPERIDYLIDENE) -5H-BENZO[5,6] CYCLOHEPTA[1,2-b]PYRIDINE |
| 01/14/1999 | WO1999001449A1 2-substituted 4,5-diaryl imidazoles |
| 01/14/1999 | WO1999001448A1 5-(2-ethyl-2h-tetrazol-5-y1)-1-methyl-1,2,3,6-tetrahydropyridine maleate |
| 01/14/1999 | WO1999001444A1 Polymorphic form of the tachykinin receptor antagonist 2-(r)-(1-(r) -(3,5-bis(trifluoromethyl) phenyl)ethoxy)-3-(s)-(4-fluoro) phenyl-4-(3-5 (-oxo-1h,4h-1,2,4,-triazolo) methylmorpholine |
| 01/14/1999 | WO1999001439A1 Aryl-and arylamino-substituted heterocycles as corticotropin releasing hormone antagonists |
| 01/14/1999 | WO1999001438A1 New compounds |
| 01/14/1999 | WO1999001437A1 Compounds |
| 01/14/1999 | WO1999001435A1 (1h-imidazol-4-yl)piperidine derivatives, preparation and application in therapy |
| 01/14/1999 | WO1999001434A1 Inhibitors of farnesyl protein transferase |
| 01/14/1999 | WO1999001427A2 Novel nitric oxide-releasing amidine- and enamine-derived diazeniumdiolates, compositions and uses thereof and method of making same |
| 01/14/1999 | WO1999001426A1 4-bromo or 4-iodo phenylamino benzhydroxamic acid derivatives and their use as mek inhibitors |
| 01/14/1999 | WO1999001421A1 2-(4-bromo or 4-iodo phenylamino) benzoic acid derivatives and their use as mek inhibitors |
| 01/14/1999 | WO1999001416A2 1-amino-alkylcyclohexane nmda receptor antagonists |
| 01/14/1999 | WO1999001158A1 Improved method for transferring nucleic acid into the striped muscle and combination therefor |
| 01/14/1999 | WO1999001157A1 Improved method for transferring nucleic acid into multicelled eukaryotic organism cells and combination therefor |
| 01/14/1999 | WO1999001151A1 Use of growth hormone in compositions for treating insulin resistance in the heart and for enhancing protein kinase b (pkb) activity |
| 01/14/1999 | WO1999001136A1 Novel substituted imidazole compounds |
| 01/14/1999 | WO1999001135A1 Pharmaceutical compositions containing eletriptan hemisulphate and caffeine |
| 01/14/1999 | WO1999001133A1 Pharmaceutical compositions for oral administration, comprising an active substance and a cyclodextrin |
| 01/14/1999 | WO1999001131A1 Novel substituted imidazole compounds |
| 01/14/1999 | WO1999001130A1 Novel substituted imidazole compounds |
| 01/14/1999 | WO1999001128A1 Certain diarylimidazole derivatives; a new class of npy specific ligands |
| 01/14/1999 | WO1999001127A1 Compounds and methods |
| 01/14/1999 | WO1999001126A1 Pharmaceutical compositions comprising alkanoyl l-carnitine in combination with a statine for treating pathologies brought about by an altered lipid metabolism |
| 01/14/1999 | WO1999001123A1 Low dosed 15-desoxyspergualine preparations |
| 01/14/1999 | WO1999001118A2 Antioxidant enhancement of therapy for hyperproliferative conditions |
| 01/14/1999 | WO1999001117A2 Inhibitors of nf-kappab as activators of hsf and inducers of heat shock proteins |
| 01/14/1999 | WO1999001113A1 Gelatine encapsulated solution dosage forms of sertraline |
| 01/14/1999 | WO1999001033A1 Compositions and methods for reducing respiratory depression and attendant side effects of mu opioid compounds |
| 01/14/1999 | WO1998045276A3 4,4-disubstituted-3,4-dihydro-2(1h)-quinazolinones useful as hiv reverse transcriptase inhibitors |
| 01/14/1999 | WO1998042729A3 Steroid sulfamates, method for the production and use thereof |
| 01/14/1999 | WO1998040097A3 Bovine respiratory and enteric coronavirus as a vaccine |
| 01/14/1999 | WO1998038986A3 Use of carvedilol or derivatives thereof for the manufacture of a medicament for the prevention and treatment of viral infections |
| 01/14/1999 | WO1998038212A3 Chimeric polypeptides containing chemokine domains |
| 01/14/1999 | WO1998036067A3 Secreted proteins and polynucleotides encoding them |
| 01/14/1999 | WO1998035020A3 Methods for modulating hematopoiesis and vascular growth |
| 01/14/1999 | WO1998034952A3 Il-2 gene expression and delivery systems and uses |
| 01/14/1999 | DE19729810A1 Mittel zur Sepsistherapie, seine Herstellung und seine Verwendung Means for sepsis therapy, its preparation and its use |
| 01/14/1999 | DE19728996A1 Triazolverbindungen und deren Verwendung Triazole compounds and the use thereof |
| 01/14/1999 | CA2297181A1 Cyclic azapeptides |
| 01/14/1999 | CA2296014A1 Aryl-and arylamino-substituted heterocycles as corticotropin releasing hormone antagonists |
| 01/14/1999 | CA2295762A1 Novel cycloalkyl substituted imidazoles |
| 01/14/1999 | CA2295748A1 Pharmaceutical compositions comprising alkanoyl l-carnitine in combination with a statine for treating pathologies brought about by an altered lipid metabolism |
| 01/14/1999 | CA2295228A1 Novel substituted imidazole compounds |
| 01/14/1999 | CA2295212A1 Secreted proteins and polynucleotides encoding them |
| 01/14/1999 | CA2294898A1 Certain diarylimidazole derivatives; a new class of npy specific ligands |
| 01/14/1999 | CA2294882A1 Compounds |
| 01/14/1999 | CA2294824A1 Use of growth hormone in compositions for treating insulin resistance in the heart and for enhancing protein kinase b (pkb) activity |
| 01/14/1999 | CA2294802A1 Improved method for transferring nucleic acid into multicelled eukaryotic organism cells and combination therefor |
| 01/14/1999 | CA2294793A1 Improved method for transferring nucleic acid into the striped muscle and combination therefor |
| 01/14/1999 | CA2294785A1 Low dosed 15-desoxyspergualine preparations |
| 01/14/1999 | CA2294770A1 Compounds and methods |
| 01/14/1999 | CA2294764A1 Inhibitors of nf-kappab as activators of hsf and inducers of heat shock proteins |
| 01/14/1999 | CA2294746A1 New compounds |
| 01/14/1999 | CA2294734A1 Compounds |
| 01/14/1999 | CA2294530A1 Inhibitors of farnesyl protein transferase |
| 01/14/1999 | CA2294524A1 Novel substituted imidazole compounds |
| 01/14/1999 | CA2294522A1 Novel substituted imidazole compounds |
| 01/14/1999 | CA2294193A1 Azetidinylpropylpiperidine derivatives, intermediates and use as tachykinin antagonists |
| 01/14/1999 | CA2294117A1 Imidazopyrimidines and imidazopyridines for the treatment of neurological disorders |
| 01/14/1999 | CA2293501A1 Nitric oxide-releasing amidine-derived diazeniumdiolates, compositions and uses thereof |
| 01/14/1999 | CA2293324A1 5-(2-ethyl-2h-tetrazol-5-yl)-1-methyl-1,2,3,6-tetrahydropyridine maleate |
| 01/14/1999 | CA2291758A1 2-substituted 4,5-diaryl imidazoles |
| 01/14/1999 | CA2290509A1 2-(4-bromo or 4-iodo phenylamino) benzoic acid derivatives and their use as mek inhibitors |
| 01/14/1999 | CA2242559A1 Agents for the prevention and/or treatment of radiation-induced disorders |
| 01/14/1999 | CA2236489A1 Novel compounds |
| 01/13/1999 | EP0890647A2 PcrA, novel polypeptide of the DNA helicases family |
| 01/13/1999 | EP0890644A2 MurA gene from Staphylococcus aureus encoding DP-N-Acetylglucosamine enolpyruvyl transferase |
| 01/13/1999 | EP0889971A1 Phosphatase modulator |
| 01/13/1999 | EP0889961A2 Monocyte chemotactic protein-5 materials and methods |
| 01/13/1999 | EP0889907A1 MONOCLONAL ANTIBODIES BINDING HUMAN GROWTH HORMONE (hGH) |
| 01/13/1999 | EP0889894A1 Phosphoramidates and phosphinic amides, their use to modulate the activity of endothelin |
| 01/13/1999 | EP0889893A1 Azaspiroderivatives |
| 01/13/1999 | EP0889892A1 Azaspiro derivatives |
| 01/13/1999 | EP0889891A1 4-[(thien-2-yl)methyl]imidazole derivatives having alpha2-adrenoceptor agonistic activity |
| 01/13/1999 | EP0889889A1 Piperazine and piperidine compounds |
| 01/13/1999 | EP0889888A1 Novel treatment for cns injuries |
| 01/13/1999 | EP0889887A1 Novel treatment for cns injuries |
| 01/13/1999 | EP0889884A1 1,2,4-triazine derivatives for the inhibition of protein glycosylation |
| 01/13/1999 | EP0889880A1 Eprosartan dihydrate and a process for its production and formulation |
| 01/13/1999 | EP0889878A1 Bisarylcyclobutene derivates as cyclooxygenase inhibitors |
| 01/13/1999 | EP0889877A1 META-SUBSTITUTED PHENYLENE DERIVATIVES AND THEIR USE AS ALPHAvBETA3 INTEGRIN ANTAGONISTS OR INHIBITORS |
| 01/13/1999 | EP0889876A1 Meta-substituted phenylene sulphonamide derivatives |
| 01/13/1999 | EP0889875A1 Cyclopropyl alkanoic acid derivatives |
| 01/13/1999 | EP0889732A1 Macrophage stimulating protein for the treatment of gastrointestinal disorders |